(Q24797305)

17

0 references

David L. Duffy

3

David L Duffy

0 references

Nirmala Pandeya

Nirmala Pandeya

4

0 references

Graham Giles

15

Graham G Giles

0 references

Douglas F. Easton

18

Douglas F Easton

0 references

John Hopper

16

John L Hopper

0 references

Amanda Spurdle

1

Amanda B Spurdle

0 references

Melissa C. Southey

14

Melissa C Southey

0 references

Gillian S Dite

12

Gillian S Dite

0 references

Carmel Apicella

13

Carmel Apicella

0 references

Antonis C Antoniou

2

Antonis C Antoniou

0 references

Susan Peock

7

Susan Peock

0 references

Beth Newman

11

Beth Newman

0 references

author name string

Livia Kelemen

5

0 references

Xiaoqing Chen

6

0 references

Margaret R Cook

8

0 references

Paula L Smith

9

0 references

David M Purdie

Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA)

10

0 references

language of work or name

English

0 references

publication date

2005

0 references

published in

Breast Cancer Research

0 references

volume

7

0 references

issue

2

0 references

page(s)

R176-83

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064126

The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064126

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064126

Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064126

A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064126

BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064126

CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064126

Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064126

Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064126

Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064126

Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064126

The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064126

De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064126

Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype

28 November 2018

1 reference

12 December 2020

Male breast cancer and the androgen receptor gene

1 reference

12 December 2020

Identification of an exon 3 deletion splice variant androgen receptor mRNA in human breast cancer

1 reference

12 December 2020

Breast cancer in Australian women under the age of 40

1 reference

12 December 2020

Androgen Receptor Exon 1 CAG Repeat Length and Breast Cancer in Women Before Age Forty Years

1 reference

12 December 2020